Pay in 4 interest-free payments of $40.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
(2014) Nature
Valrubicin in combination with radiation enhances the cytotoxicity
1 μM and IL4 driven proliferation with IC50=0
3 µM) and a TGFβ receptor inhibitor (SB431542
Double-blind study of pardoprunox
NV-5138 C AR Degrader-4 TFA (2014) NatureNV 5138 is an orally and centrally active small molecule drug for the treatment of major depressive disorder (MDD). It directly and selectively activates the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway by binding to and modulating sestrin2, a leucine amino acid sensor and upstream regulatory pathway. The mTORC1 pathway is the same signaling pathway that the NMDA receptor antagonist ketamine activates in the medial prefrontal
US$ 1026.35
US$ 200.00
US$ 262.50
US$ 179.85
US$ 1474.50